The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease

BACKGROUND: Although major guidelines uniformly recommend iron supplementation and erythropoietin stimulating agents (ESAs) for managing chronic anemia in persons with chronic kidney disease (CKD), there are differences in the recommended hemoglobin (Hb) treatment target and no guidelines consider t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarnoff, Benjamin O., Hoerger, Thomas J., Simpson, Siobhan A., Pavkov, Meda E., Burrows, Nilka R., Shrestha, Sundar S., Williams, Desmond E., Zhuo, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942058/
https://www.ncbi.nlm.nih.gov/pubmed/27404556
http://dx.doi.org/10.1371/journal.pone.0157323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942058/
https://www.ncbi.nlm.nih.gov/pubmed/27404556
http://dx.doi.org/10.1371/journal.pone.0157323

Ejemplares similares